IP Verse

Lactobacillus Rhamnosus And Bifidobacterium Animalis Subsp. Lactis For Use In Prevention Or Treatment Of Upper Respiratory Tract Infections

Patent No. EP2802333 (titled "Lactobacillus Rhamnosus And Bifidobacterium Animalis Subsp. Lactis For Use In Prevention Or Treatment Of Upper Respiratory Tract Infections") was filed by CHR Hansen on Jan 14, 2013. The application was issued on Mar 11, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
N&H DENMARK APSDec 10, 2020D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2802333

CHR HANSEN
Application Number
EP13702584A
Filing Date
Jan 14, 2013
Status
Revoked
Oct 25, 2024
Publication Date
Mar 11, 2020
External Links
Slate, Register , Google Patents